Runben Biotechnology Co., Ltd.

SHSE:603193 Stock Report

Market Cap: CN¥9.6b

Runben Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 603193?
Owner TypeNumber of SharesOwnership Percentage
Institutions30,258,4707.48%
General Public33,026,5128.16%
Individual Insiders133,840,33233.1%
Private Companies207,468,00051.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 90.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
44.6%
Guangzhou Zhuofan Investment Holding Co., Ltd
180,387,000CN¥4.3b0%no data
19.1%
Guiqin Zhao
77,112,000CN¥1.8b0%no data
8.5%
Colm O'Connell
34,390,332CN¥818.5m0%no data
5.52%
Songjuan Bao
22,338,000CN¥531.6m0%no data
5.29%
Guangzhou Zhuofan Chengguang Investment Consulting Partnership (Limited Partnership)
21,420,000CN¥509.8m0%no data
1.17%
Guangzhou Zhuofan Hesheng Investment Holding Partnership (Limited Partnership)
4,743,000CN¥112.9m0%no data
0.95%
First State Cinda Fund Management Company Limited
3,826,680CN¥91.1m0%0.22%
0.73%
CIB Fund Management Co., Ltd
2,942,426CN¥70.0m0%0.59%
0.61%
Shanghai Orient Securities Asset Management Co., Ltd.
2,487,981CN¥59.2m0%0.07%
0.54%
Taikang Asset Management Co., Ltd.
2,192,600CN¥52.2m0%0.14%
0.48%
CPIC Fund Management Co., Ltd.
1,957,543CN¥46.6m0%0.08%
0.36%
Dacheng Fund Management Co., Ltd.
1,461,738CN¥34.8m0%0.03%
0.33%
GF Fund Management Co., Ltd.
1,342,733CN¥32.0m0%0.01%
0.32%
China Asset Management Co. Ltd.
1,291,412CN¥30.7m0%no data
0.31%
ICBC Credit Suisse Asset Management Co., Ltd.
1,259,502CN¥30.0m0%0.02%
0.29%
Chang Xin Asset Management Corporation Ltd.
1,167,288CN¥27.8m0%0.15%
0.25%
Bosera Asset Management Co., Ltd.
1,025,946CN¥24.4m0%0.01%
0.23%
Guangzhou Zhuofan Juyuan Investment Partnership (Limited Partnership)
918,000CN¥21.8m0%no data
0.22%
Foresight Fund Management Company
876,600CN¥20.9m0%0.06%
0.2%
Penghua Fund Management Co., Ltd.
815,228CN¥19.4m0%0.02%
0.18%
Zhonghai Fund Management Co., Ltd.
719,205CN¥17.1m0%0.27%
0.18%
China International Capital Corporation Hong Kong Asset Management Limited
715,132CN¥17.0m0%0.09%
0.17%
Goldman Sachs Group, Investment Banking and Securities Investments
703,218CN¥16.7m0%no data
0.17%
Shanghai Guotai Junan Securities Asset Management Co., Ltd.
670,745CN¥16.0m0%0.05%
0.17%
Invesco Great Wall Fund Management Co. Ltd
669,841CN¥15.9m0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 19:10
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Runben Biotechnology Co., Ltd. is covered by 12 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiyue ZhangChasing Securities
Junhao FanChina International Capital Corporation Limited
Zhuonan XuChina International Capital Corporation Limited